[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Omnicell Inc (OMCL)

Omnicell Inc (OMCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,750,942
  • Shares Outstanding, K 45,479
  • Annual Sales, $ 1,185 M
  • Annual Income, $ 2,050 K
  • EBIT $ 34 M
  • EBITDA $ 123 M
  • 60-Month Beta 0.97
  • Price/Sales 1.53
  • Price/Cash Flow 14.43
  • Price/Book 1.44

Options Overview Details

View History
  • Implied Volatility 50.36% (-5.03%)
  • Historical Volatility 38.18%
  • IV Percentile 30%
  • IV Rank 28.99%
  • IV High 83.54% on 03/27/26
  • IV Low 36.81% on 06/16/26
  • Expected Move (DTE 28) 0.34 (0.87%)
  • Put/Call Vol Ratio 6.00
  • Today's Volume 35
  • Volume Avg (30-Day) 35
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 1,310
  • Open Int (30-Day) 1,092
  • Expected Range 38.71 to 39.39

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.31
  • Number of Estimates 2
  • High Estimate $0.31
  • Low Estimate $0.30
  • Prior Year $0.24
  • Growth Rate Est. (year over year) +29.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.55 +6.84%
on 06/11/26
44.89 -13.01%
on 05/28/26
-4.17 (-9.65%)
since 05/18/26
3-Month
31.75 +22.99%
on 03/31/26
46.89 -16.72%
on 04/28/26
+5.02 (+14.75%)
since 03/18/26
52-Week
26.84 +45.46%
on 07/18/25
55.00 -29.00%
on 01/13/26
+10.78 (+38.13%)
since 06/18/25

Most Recent Stories

More News
1 Profitable Stock with Exciting Potential and 2 That Underwhelm

1 Profitable Stock with Exciting Potential and 2 That Underwhelm

SOLV : 75.43 (+1.17%)
OMCL : 39.05 (+1.43%)
CR : 214.90 (+2.75%)
Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business

Seasoned healthcare executive with deep expertise in specialty pharmacy operations named Senior Vice President and General Manager

OMCL : 39.05 (+1.43%)
3 Russell 2000 Stocks That Fall Short

3 Russell 2000 Stocks That Fall Short

OMCL : 39.05 (+1.43%)
TMHC : 71.58 (-0.01%)
ENR : 21.520 (+7.76%)
Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, announced that it will present at the Goldman Sachs 47th Annual Global Healthcare...

OMCL : 39.05 (+1.43%)
3 Healthcare Stocks We Think Twice About

3 Healthcare Stocks We Think Twice About

OMCL : 39.05 (+1.43%)
PNTG : 33.44 (-3.30%)
JAZZ : 224.66 (-1.00%)
Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the Bunch

Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the Bunch

OMCL : 39.05 (+1.43%)
3 Reasons to Avoid OMCL and 1 Stock to Buy Instead

3 Reasons to Avoid OMCL and 1 Stock to Buy Instead

OMCL : 39.05 (+1.43%)
3 Stocks Under $50 with Warning Signs

3 Stocks Under $50 with Warning Signs

OMCL : 39.05 (+1.43%)
LKQ : 25.80 (+3.12%)
KSS : 17.25 (+3.98%)
3 Cash-Producing Stocks We Keep Off Our Radar

3 Cash-Producing Stocks We Keep Off Our Radar

LAUR : 36.43 (+1.08%)
OMCL : 39.05 (+1.43%)
CMI : 716.86 (-0.13%)
The 5 Most Interesting Analyst Questions From Omnicell’s Q1 Earnings Call

The 5 Most Interesting Analyst Questions From Omnicell’s Q1 Earnings Call

OMCL : 39.05 (+1.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution,...

See More

Key Turning Points

3rd Resistance Point 41.54
2nd Resistance Point 40.48
1st Resistance Point 39.76
Last Price 39.05
1st Support Level 37.98
2nd Support Level 36.92
3rd Support Level 36.20

See More

52-Week High 55.00
Fibonacci 61.8% 44.24
Fibonacci 50% 40.92
Last Price 39.05
Fibonacci 38.2% 37.60
52-Week Low 26.84

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.